Genix Pharmaceuticals Corporation reported earnings results for the full year ended October 31, 2021. For the full year, the company reported net loss was CAD 1.65 million compared to CAD 0.718663 million a year ago. Basic loss per share from continuing operations was CAD 0.03 compared to CAD 0.02 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.04 CAD | -20.00% | -33.33% | +100.00% |
1st Jan change | Capi. | |
---|---|---|
+100.00% | 1.73M | |
+13.21% | 8.15B | |
+3.16% | 7.52B | |
+12.30% | 6.65B | |
-5.71% | 3.73B | |
-6.99% | 3.72B | |
-4.78% | 1.31B | |
+12.61% | 972M | |
-37.22% | 958M | |
-15.02% | 876M |
- Stock Market
- Equities
- GENX Stock
- News Genix Pharmaceuticals Corporation
- Genix Pharmaceuticals Corporation Reports Earnings Results for the Full Year Ended October 31, 2021